Review

The cardiovascular action of hexarelin

Journal of geriatric cardiology : JGC, 2014 Sep. Mao Y, Tokudome T, Kishimoto I.

Study type

Review

Subjects

Not classified in PubMed MeSH

Journal

Journal of geriatric cardiology : JGC

Published

2014 Sep

PubMed

PMID 25278975 ↗

DOI

10.11909/j.issn.1671-5411.2014.03.007 ↗

Full text

Free on PubMed Central (PMC4178518) ↗

Where PepCue cites this

This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.

Hexarelin →

Other papers on Hexarelin

Randomized controlled trial · 1999

Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humans

Clinical trial · 2001

Growth hormone-independent cardiotropic activities of growth hormone-releasing peptides in normal subjects, in patients with growth hormone deficiency, and in patients with idiopathic or ischemic dilated cardiomyopathy

Clinical trial · 1999

The effect of chronic hexarelin administration on the pituitary-adrenal axis and prolactin

PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page